HAI 2023 POSTER SESSIONS
Click the “+” to open each module; tables can be sorted by clicking on each item of the header row (board number, poster title, authors and presenter, respectively). Additionally, each table is searchable (use the search field located at the top right of each module).
Please note that we reserve the right to re-arrange the poster allocation.
POSTER SESSIONS: 1A - Wednesday, January 11 - 9:45 - 10:30 am; 1B - Wednesday, January 11, 4:00 - 4:45 pm
Board # | Title | Authors | Presenter | Presenter/Affiliation |
---|---|---|---|---|
1 | Effects of de-facing PET and MRI scans on clinical correlations analyses | Schwarz | Kremers | Weigand | Prakaashana | Senjem | Lowe | Gunter | Kantarci | Vemuri | Petersen | Knopman | Jack | Schwarz, Christopher | Christopher Schwarz, Mayo Clinic, Rochester, MN, US |
2 | Non-invasive quantification and SUVR validation of [18F]-florbetaben with total-body EXPLORER PET | Holy | Alfaro | Fletcher | Bhattarai | Spencer | Cherry | DeCarli | Fan | Holy, Emily | Emily Holy, Department of Neurology, UC Davis Health, Davis, CA, US |
3 | PET imaging probe development for aggregated alpha-synuclein | Gomperts | Liu | Bai | Xu | Rose | Celikag | Ndayisaba | Khurana | Bartels | Wang | Gomperts, Stephen | Stephen Gomperts, Department of Neurology, Massachusetts General Hospital, Boston, MA, US |
4 | Cross-modality transformer for low-dose tau PET imaging | Jang | Lois | Becker | Thibault | Price | Johnson | El Fakhri | Gong | Gong, Kuang | Kuang Gong, Gordon Center for Medical Imaging, Department of Imaging, Massachusetts General Hospital, Boston, MA, US |
5 | Tau PET positivity reveals Alzheimers disease related fast cognitive decline | Ioannou | Bucci | Nordberg | Chiotis | Ioannou, Konstantinos | Konstantinos Ioannou, Nordberg Translational Molecular Imaging Lab, Division of Clinical Geriatrics, Center for Alzheimers Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, SE |
6 | Positive 18F-APN-1607 tau PET imaging findings in patients with Progressive Supranuclear Palsy-like extrapyramidal symptoms caused by TBK1 mutations | Liu | Lu | Sun | Li | Yen | Jang | Zuo | Wang | Liu, Feng-Tao | Feng-Tao Liu, Department of Neurology & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, CN |
7 | In vivo visualization of tau deposits in corticobasal syndrome by 18F-Florzolotau PET | Liu | Lu | Li | Jiao | Chen | Yao | Liang | Ge | Li | Shen | Wu | Sun | Wu | Yen | Zuo | Wang | Liu, Feng-Tao | Feng-Tao Liu, Department of Neurology, National Research Center for Aging and Medicine, National Center for Neurological Disorders, and State Key Laboratory of Medical Neurobiology, Huashan Hospital, Fudan University, Shanghai, CN |
8 | Imaging neuroinflammation with astrocyte-PET and bio-fluid biomarkers in patients with cognitive impairment | Chiotis | Jelic | Rodriguez-Vieitez | Savitscheva | Wall | Antoni | Nordberg | Chiotis, Konstantinos | Konstantinos Chiotis, Department NVS, Karolinska Institutet, Stockholm, SE |
9 | [18] Flortaucipir PET and Diffusion Tensor Tractography Coregistration can Enhance Detection of Brain Changes Associated with Progressive Apraxia of Speech | Gatto | Duffy | Utianski | Clark | Botha | Machulda | Lowe | Josephs | Whitwell | Gatto, Rodolfo G. | Rodolfo G. Gatto, Division of Neurology, Mayo Clinic, Rochester, MN, US |
10 | Towards a simplified flortaucipir-PET read method for assessing tau burden | Tunali | Iaccarino | Ducker | Patel | DiFabbio | Kowaleski | Arora | Kim | Lu | Pontecorvo | Shcherbinin | Tunali, Ilke | Ilke Tunali, Eli Lilly and Company, Indianapolis, IN, US |
12 | Digital clock drawing performance is associated with tau deposition measured with PET in preclinical Alzheimers disease | Fu | Rentz | Mayblyum | Thibault | Buckley | Das | Papp | Sperling | Penney | Davis | Johnson | Price | Fu, Jessie Fang-Lu | Jessie Fang-Lu Fu, Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, US |
13 | [18F]RO-948 Tau PET Retention and Correlation with Fluid Biomarkers in the Early AD Continuum | Shekari | González Escalante | Milà-Alomà | Falcon | Niñerola-Baizán | Tonietto | Borroni | Klein | J. Ashton | K. Karikari | Lantero-Rodriguez | Snellman | Ortiz | Vanmechelen | Minguillón | Fauria | Perissinotti | Molinuevo | Zetterberg | Blennow | Grau-Rivera | Suárez-Calvet | Domingo Gispert | Shekari, Mahnaz | Mahnaz Shekari, Barcelona?eta Brain Research Center (BBRC), Pasqual Maragall Foundation,, Barcelona, ES |
14 | Regional tau predicts glucose hypometabolism in autosomal dominant Alzheimers disease: Findings from the Colombia-Boston (COLBOS) biomarker study | Langella | Kaplan | Baena | Londono | Munera | Vila-Castelar | Alvarez | Vidal | Properzi | Sanchez | Sperling | Johnson | Lopera | Hanseeuw | Quiroz | Langella, Stephanie | Stephanie Langella, Massachusetts General Hospital / Harvard Medical School, Boston, MA, US |
15 | Is tau PET a robust biomarker for chronic traumatic encephalopathy? | Krishnadas | Doré | Lamb | Guzman | Ponsford | Hicks | Williams | Feizpour | Villemagne | Rowe | Krishnadas, Natasha | Natasha Krishnadas, Florey Institute of Neurosciences & Mental Health, Melbourne, AU |
16 | Centiloid scale measure of amyloid PET by CT of PET/CT equipment | Matsuda | Hanyu | Kaneko | Matsuda, Hiroshi | Hiroshi Matsuda, Fukushima Medical University, Fukushima, JP |
17 | Successful cognitive aging is associated with less brain atrophy and lower tau deposition | Pezzoli | Giorgio | Harrison | Martersteck | Jagust | Pezzoli, Stefania | Stefania Pezzoli, Helen Wills Neuroscience Institute, University of California, Berkeley, CA, US |
18 | Subcortical flortaucipir PET and susceptibility analyses to differentiate progressive supranuclear palsy clinical variants and corticobasal syndrome | Satoh | Arani | Schwarz | Senjem | Ali | Jack | Lowe | Josephs | Whitwell | Satoh, Ryota | Ryota Satoh, Mayo Clinic, Rochester, MN, US |
19 | Temporal associations of plasma and PET Alzheimers disease biomarkers using a non-linear mixed effects model | Cogswell | Lundt | Therneau | Graff-Radford | Schwarz | Senjem | Gunter | Vemuri | Petersen | Jack Jr | Cogswell, Petrice | Petrice Cogswell, Department of Radiology, Mayo Clinic, Rochester, MN, US |
20 | Beta-amyloid accumulates at a faster rate in individuals with Down syndrome | McVea | DiFilippo | McLachlan | Murali | Zammit | Johnson | Betthauser | Stone | Tudorascu | Laymon | Klunk | Cohen | Handen | Christian | McVea, Andrew | Andrew McVea, University of Wisconsin - Madison, Madison, WI, US |
21 | Magnitude of MK6240 off-target binding correlated with spill-in effects in target regions | McVea | DiFilippo | McLachlan | Johnson | Betthauser | Christian | McVea, Andrew | Andrew McVea, University of Wisconsin - Madison, Madison, WI, US |
22 | Amyloid and tau pathology associated with different cognitive declines in cognitively normal older people | Chen | Juarez | Baker | Harrison | Landau | Jagust | Chen, Xi | Xi Chen, University of California, Berkeley, Berkeley, CA, US |
23 | Future amyloid accumulation status affects the preservation of peripheral whole-blood gene co-expression networks at baseline in asymptomatic Alzheimers disease | Luckett | Zielonka | Schaeverbeke | Adamczuk | Van Laere | Dupont | Cleynen | Vandenberghe | Luckett, Emma | Emma Luckett, Laboratory for Cognitive Neurology, KU Leuven, Leuven, BE |
24 | Validation of [18f]florbetaben PET quantitation based on the analysis of 15 software pipelines | Jovalekic | Roé-Vellvé | Koglin | Lagos Quintana | Nelson | Diemling | Lilja | Gómez González | Doré | Bourgeat | Whittington | Gunn | Stephens | Bullich | Stephens, Andrew | Andrew Stephens, Life Molecular Imaging, Berlin, DE |
25 | Preprocessing 10,700 real-world amyloid-PET scans from the IDEAS study: the Good, the Bad and the Ugly | Mejia Perez | Mundada | Blazhenets | Soleimani-Meigooni | Zeltzer | Cho | Ranasinghe | Windon | Yadollahikhales | Iaccarino | Carrillo | Gatsonis | March | Apgar | Siegel | Hilner | Whitmer | Rabinovici | La Joie | Mejia Perez, Jhony | Jhony Mejia Perez, Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, US |
26 | Longitudinal tau-PET differs between progressive apraxia of speech subtypes | Tetzloff | Martin | Duffy | Clark | Utianski | Botha | Machulda | Schwarz | Senjem | Jack Jr. | Lowe | Josephs | Whitwell | Tetzloff, Katerina A. | Katerina A. Tetzloff, Mayo Clinic Department of Neurology, Rochester, MN, US |
27 | Cross-sectional PET Analyses in the Longitudinal Early-onset Alzheimers Disease Study (LEADS) | Cho | Mundada | Apostolova | Carrillo | Shankar | Amuiri | Zeltzer | Windon | Soleimani Meigooni | Tanner | Lawhn Heath | Aisen | Eloyan | Koeppe | Iaccarino | Dickerson | La Joie | Rabinovici | Cho, Hanna | Hanna Cho, Memory and Aging Center, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, US |
28 | Dynamic amyloid PET: relationships to tau PET and cognition in Alzheimers disease | Raman | Charniaux | Murchison | Fang | Tzabari | Liu | Morris | Chen | Joseph-Mathurin | Ponisio | Flores | Kennedy | Benzinger | Roberson | McConathy | Raman, Fabio | Fabio Raman, The University of Alabama at Birmingham, Department of Radiology, Birmingham, AL, US |
29 | Spatial extent and intensity of Alzheimer-associated tau PET burden is greater in agrammatic than logopenic primary progressive aphasia | Martersteck | Sridhar | Coventry | Weintraub | Mesulam | Rogalski | Martersteck, Adam | Adam Martersteck, Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University, Chicago, IL, US |
30 | Comparing PI2620 and Flortaucipir in Progressive Supranuclear Palsy Subjects | Thomas | Blazhenets | La Joie | Rabinovici | Heuer | Jagust | Boxer | Baker | Thomas, Wesley | Wesley Thomas, University of California, Berkeley, Berkeley, CA, US |
31 | Assessing a universal neocortical mask for Centiloid quantification | Bourgeat | Dore | Rowe | Benzinger | Tosun | Goyal | LaMontagne | Jin | Weiner | Morris | Masters | Fripp | Villemagne | Feizpour, Azadeh | Azadeh Feizpour, Austin Health, AU |
32 | Relationships between Neuronal Hyperactivity, Stress Susceptibility, and Alzheimers Disease pathology | Sharp | Razlighi | Oh | Oh, Hwamee | Hwamee Oh, Carney Institute for Brain Science, Brown University, Providence, RI, US |
33 | A/T/N, cognitive, health and lifestyle differences across white matter hyperintensities groups in aged 45-85 years adults: Results from the Wisconsin Registry for Alzheimer's Prevention (WRAP) | Du | Burghy | Cody | Hermann | Jonaitis | Betthauser | Chin | Cadman | Rivera-Rivera | Peret | Johnson | Rowley | Pompa | Lose | Christian | Janelidze | Hansson | Johnson | Eisenmenger | Koscik | Du, Lianlian | Lianlian Du, Wisconsin Alzheimer's Institute, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, US |
34 | Medial temporal 18F-MK6240 levels are associated with global graph characteristics of functional connectivity from high-density EEG in the asymptomatic and prodromal stage of Alzheimer disease | Spruyt | Reinartz | Meade | Khachatryan | Van Hulle | Van Laere | Dupont | Vandenberghe | Spruyt, Laure | Laure Spruyt, Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, BE |
35 | Longitudinal PET assessments of tau pathologies in progressive supranuclear palsy with 18F-florzolotau (PM-PBB3/APN-1607) | Endo | Takado | Tagai | Matsuoka | Kokubo | Hirata | Kataoka | Oya | Matsumoto | Kurose | Ichihashi | Hatano | Saiki | Hirano | Nakano | Furukawa | Takeda | Isose | Imai | Yagi | Nishida | Yuasa | Ono | Seki | Takahata | Tokuda | Shinotoh | Shimada | Kawamura | Zhang | Higuchi | Endo, Hironobu | Hironobu Endo, Department of Functional Brain Imaging, Institute for Quantum Medial Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, Chiba, JP |
36 | Head-to-head comparison of tau PET tracers [18F]PI2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort | Klein | Marquié | Sotolongo-Grau | Roé-Vellvé | Bullich | Tartari | Sanabria | García-Sánchez | Borroni | Galli | Tonietto | Pérez-Martínez | Tárraga | Ruiz | Stephens | Boada | Klein, Gregory | Gregory Klein, Roche Pharma Research and Early Development, Basel, CH |
POSTER SESSIONS: 2A - Thursday, January 12 - 10:45 - 11:30 am; 2B - Thursday, January 12, 4:00 - 4:45 pm
Board # | Title | Authors | Presenter | Presenter/Affiliation |
---|---|---|---|---|
37 | Regional [F18]AV1451 uptake in progressive apraxia of speech with and without Alzheimers disease, dysexecutive, and logopenic variants of Alzheimers disease | Switzer | Corriveau-Lecavalier | Lowe | Jones | Ramanan | Machulda | Graff-Radford | Boeve | Knopman | Jack | Petersen | Josephs | Whitwell | Botha | Switzer, Aaron R | Aaron Switzer, Mayo Clinic, Rochester, MN, US |
38 | Estimation of Native Spatial Resolution in Clinical Positron Emission Tomography Imaging Data | Galli | Tonietto | Klein | Holiga | Miho | Knopf | Galli, Christopher | Christopher Galli, Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F.Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland, Basel, CH |
39 | Neuroinflammation Co-Localizes with Tau in Early-Onset MCI patients | Finn | Appleton | Bradbury | Yu | Faridar | Beers | Appel | Fujita | Masdeu | Pascual | Finn, Quentin | Quentin Finn, Nantz National Alzheimer Center, Houston Methodist Neurological and Research Institute, Houston, TX, US |
40 | Lower locus coeruleus integrity identifies elevated entorhinal tau in low amyloid individuals and is associated with faster clinical progression | Engels-Domínguez | A. Koops | M. Riphagen | F. Smegal | Bueichekú | Becker | M. Kwong | M. Rentz | H. Salat | A. Sperling | A. Johnson | I. L. Jacobs | Engels-Domínguez, Nina | Nina Engels-Domínguez, Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, US |
41 | Substantia nigra 18F-PI-2620 PET signal is associated with motor impairment in Lewy body disease | Winer | Vossler | Young | Romero | Shahid | Abdelnour | Anders | Shen | Mormino | Poston | Winer, Joseph | Joseph Winer, Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, US |
42 | Sex differences in A? and tau vulnerability in preclinical Alzheimers disease | Ourry | St-Onge | Mohammediyan | Yakoub | Soucy | Poirier | Breitner | Villeneuve | Ourry, Valentin | Valentin Ourry, Department of Psychiatry, Faculty of Medicine, McGill University, Montréal, QC, CA |
43 | Alzheimer's Network for Treatment and Diagnostics (ALZ-NET): Defining the future of Alzheimer's treatment, imaging and care | Whitlow | March | Rabinovici | Rafii | Atri | Daffner | Edelmayer | Gatsonis | Lopez | Porsteinsson | Possin | Salloway | Sano | Snyder | Vukmir | Wilkins | Windon | Carrillo | Whitlow, Christopher | Christopher Whitlow, American College of Radiology, Reston, VA, US |
44 | Acquisition time corrections for SUVR analyses of [18F]-PI-2620 | Young | Vossler | Winer | Romero | Anders | Shen | Poston | Davidzon | Mormino | Young, Christina | Christina Young, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, US |
45 | Longitudinal accumulation of white matter lesions is associated with amyloidosis and brain atrophy, but not systemic vascular risk | Shirzadi | Schultz | Yau | Fitzpatrick | Levin | Joseph-Mathurin | Kantarci | Preboske | Jack Jr. | Farlow | Fagan | Hassenstab | Jucker | Morris | Xiong | Karch | Levey | Gordon | Schofield | Salloway | Perrin | McDade | Levin | Cruchaga | Allegri | Fox | Goate | Day | Koeppe | Noble | Chui | Berman | Mori | Sanchez-Valle | Lee | Rosa-Neto | Ruthirakuhan | Wu | Swardfager | Benzinger | Sohrabi | Martins | Schultz | Bateman | Johnson | Sperling | Greenberg | Chhatwal | Shirzadi, Zahra | Zahra Shirzadi, Massachusetts General Hospital, Brigham and womens hospital, Harvard Medical School, Boston, MA, US |
46 | Sex-associated differences in cerebrospinal fluid and plasma biomarkers in early-onset Alzheimer's disease | Nemes | Logan | Dage | Fagan | Hammers | Manchella | Eloyan | Kostadinova | Foroud | Zetterberg | Koeppe | Aisen | Carrillo | Rabinovici | Dickerson | Apostolova | Nemes, Sára | Sára Nemes, Indiana University School of Medicine, Indiana, IN, US |
47 | Correlations between Janssen Simoa plasma p217+tau and tau PET in participants screened for Janssens Au?onomy Ph2 anti-tau trial in early Alzheimers Disease | Saad | Triana-Blatzer | Moughadam | Slemmon | Henley | Kolb | Saad, Ziad S. | Ziad S. Saad, Neuroscience Biomarkers and Global Imaging, Janssen R&D, Johnson & Johnson, San Diego, CA, US |
48 | Sleep apnea and poor sleep quality are linked to tau deposition in older women at higher risk for Alzheimers | Lui | Shepherd | Wang | Bernier | Bosompra | DeYoung | Malhotra | Sundermann | Banks | Lui, Kitty | Kitty Lui, San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, US |
49 | Machine Learning Based Tau Positivity Classification On Tau-PET Scans Considers Biological Variability And Can Aid In Decision Making | Gebre | Rial | Raghavan | Sparrman | Wiste | Schwarz | Lowe | Graff-Radford | Knopman | Petersen | Schöll | Jack Jr | Vemuri | Gebre, Robel | Robel Gebre Department of Radiology Mayo Clinic, Rochester |
50 | Impact of florbetaben acquisition timing on SUVR and centiloid values | Johns | Kennedy | Young | Younes | Vossler | Poston | Davidzon | Mormino | Johns, Emily | Emily Johns, Stanford University School of Medicine, Stanford, CA, US |
51 | Postmortem In Vitro Binding of APN-1607 to PSP and HC Globus Pallidus Homogenates | Tempest | Margolin | Paget | Campbell | Navia | Tempest, Paul | Paul Tempest, Aprinoia Theraputics, Cambridge, MA, US |
52 | Histone deacetylase tracer [11C]Martinostat behaves differently in amyloid versus synuclein rich regions in dementia with Lewy bodies | Goodheart | Yoo | Striar | Quan | Wey | Wang | Gomperts | Goodheart, Anna | Anna Goodheart, Department of Neurology, Massachusetts General Hospital, Boston, MA, US |
53 | A CenTauR scale based on 18F-MK6240 | Dore | Bourgeat | Leuzy | Huang | Krishnadas | Feizpour | Fripp | Villemagne | Rowe | Krishnadas, Natasha | Natasha Krishnadas, Florey Department of Neurosciences & Mental Health, The University of Melbourne, Melbourne, AU |
54 | Tau accumulation across the Alzheimer's disease continuum: an 18F-MK6240 AIBL study | Krishnadas | Doré | Robertson | Ward | Fowler | Masters | Bourgeat | Fripp | Villemagne | Rowe | Krishnadas, Natasha | Natasha Krishnadas, Florey Department of Neurosciences & Mental Health, The University of Melbourne, Melbourne, AU |
55 | Multi-modal analysis of myelin and neurofilament light chain in individuals at risk for Alzheimers disease using MRI, PET, and CSF biomarker assessments | Yang | Dean III | Betthauser | Carlsson | Johnson | Blennow | Zetterberg | Alexander | Bendlin | Yang, Kao Lee | Kao Lee Yang, Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, WI, US |
56 | The gut microbiota metabolite trimethylamine n-oxide is associated with white matter degeneration on the Alzheimers disease continuum | Moody | Heston | Zarbock | Blennow | Zetterberg | Rey | Ulland | Bendlin | Moody, Jason | Jason Moody, Wisconsin Alzheimers Disease Research Center, University of Wisconsin-Madison, Madison, WI, US |
57 | In vivo measures of fibrillar beta-amyloid pathology limits cognitive plasticity in healthy aging: A multi-center intervention study. | Bischof | Fellerhoff | Giehl | Drzezga | Bischof, Gerard | Gerard Bischof, University of Cologne, University Hospital of Cologne, Department of Nuclear Medicine, Multimodal Neuroimaging Group, Cologne, Germany, Cologne, DE |
58 | One Year Longitudinal Change of Tau Accumulation on [18F]PI-2620 PET in Alzheimer Spectrum | Oh | Oh | Lee | Oh | Seo | Roh | Lee | Kim | Oh, Minyoung | Minyoung Oh, Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KR |
59 | The role of vascular pathology in the association between amyloid-? and tau in cognitively unimpaired individuals | Coomans | van Westen | Pichet Binette | Strandberg | Spotorno | Palmqvist | Stomrud | Ossenkoppele | Hansson | Coomans, Emma | Emma Coomans, Radiology & Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, NL |
60 | Dual biomarker amyloid PET for improved subtype and stage inference | Scott | Coath | Dickson | McQuaid | Cash | Schott | Scott, Catherine J | Catherine J Scott, Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, GB |
61 | Standardization of Tau PET using the CenTauR Scale: Preliminary findings from BioFINDER-2 using [18F]RO948 and [18F]Flortaucipir | Leuzy | Doré | Klein | Baker | Carrillo | Charil | Collins | Collins | Haeberlein | Henscheid | Hostetler | Higuchi | Muthinson | Iaacarino | Irizarry | Jagust | Johnson | Karten | Kolb | Lopresti | Ossenkoppele | Pascoal | Pappas | Pontecorvo | Rabinovici | Raket | Bohorquez | Saad | Stephens | Mathotaarachchi | Mintun | Sivakuraman | Smith | Rowe | Villemagne | Hansson | Leuzy, Antoine | Antoine Leuzy, Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden, Malmö, SE |
62 | Plasma GFAP and NFL are correlated with measures of global cognition in EOAD and EOnonAD | Kostadinova | Hammers | Logan | Manchella | Nemes | Fagan | Foroud | Zetterberg | Kramer | Aisen | Carrillo | Rabinovici | Dickerson | Apostolova | Dage | Kostadinova, Ralitsa V. | Ralitsa V. Kostadinova, Indiana University School of Medicine, Indianapolis, IN, US |
63 | Comparisons of plasma biomarkers with 18F-Florzolotau PET in AD continuum a pilot study | Huang | Ing-Tsung | Lin | Huang | Huang, Kuo-Lun | Kuo-Lun Huang, Department of Neurology, Linkou Chang Gung Memorial Hospital, Taoyuan, TW |
64 | Validating Tau PET Staging Schemes in Relation to Cognitive Outcomes | Hammers | Lin | Logan | Risacher | Schwarz | Apostolova | Hammers, Dustin | Dustin Hammers, Indiana University School of Medicine, Department of Neurology, Indianapolis, IN, US |
65 | Shared variance between FDG metabolism and PiB tracer delivery is not predictive of cognitive decline in preclinical AD | Mayblyum | Shirzadi | Becker | Chhatwal | Farrell | Jacobs | Guehl | El Fakhri | Sperling | Price | Johnson | Schultz | Hanseeuw | Mayblyum, Danielle | Danielle Mayblyum, Massachusetts General Hospital, Boston, MA, US |
66 | Amyloid and tau PET are associated with plasma phosphorylated tau 181 and glial fibrillary acidic protein in a sample of heterogeneous dementia syndromes | Cousins | Phillips | Das | Fulop | Nasrallah | O'Brien | McMillan | Irwin | Massimo | Grossman | Wolk | Phillips, Jeffrey | Jeffrey Phillips, University of Pennsylvania, Philadelphia, PA, US |
67 | Combined and independent effects of hyperphosphorylation of tau on microglial activation | Rahmouni | Therriault | Tissot | L. Benedet | Ashton | Triana-Baltzer | Lussier | Servaes | Macedo | Stevenson | Stevenson | Kunach | Fernandez-Arias | Wang | Gauthier | Kolb | Karikari | Zetterberg | Blennow | Pascoal | Rosa-Neto | Rahmouni, Nesrine | Nesrine Rahmouni, Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, Montreal, QC, CA |
68 | Cognitive impairment is more closely associated with the regional extension of F18MK6240 tau-PET signal than with PET signal intensity or CSF tau measures | Hanseeuw | Gerard | Malotaux | Colmant | Quenon | Ivanoiu | Lhommel | Hanseeuw, Bernard | Bernard Hanseeuw, Cliniques Universitaires Saint-Luc, Brussels, BE |
69 | Disentangling spatial-temporal remote interaction between tau and Amyloid-? proteins in different stages of tau aggregations | Hojjati | Feiz | Nayak | Shteingart | Ozoria | Fernández | Devanand | Luchsinger | Stern | Razlighi | Hojjati, Seyed Hani | Seyed Hani Hojjati, Weill Cornell Medicine, New York, NY, US |
70 | Predictors of Discordance Between Pre-PET Clinical Diagnosis and Amyloid-PET Results in the Imaging DementiaEvidence for Amyloid Scanning (IDEAS) Study | Tanner | La Joie | Hanna | Iaccarino | Allen | Siegel | Hillner | Whitmer | Gatsonis | Carrillo | Rabinovici | Tanner, Jeremy | Jeremy Tanner, Memory and Aging Center, University of California San Francisco, San Francisco, CA, US |
71 | Mid-life atherosclerotic cardiovascular disease risk score and late-life AT(N) measures | Saeed | Chang | Royse | Lopresti | Snitz | Villemagne | Reis | Lopez | Cohen | Cohen, Ann | Ann Cohen, University of Pittsburgh School of Medicine, Pittsburgh, PA, US |
72 | A clinical diagnosis of Alzheimer's disease and CSF-based tau positivity are both associated with lower locus coeruleus metabolism | Koops | Dutta | Becker | Van Egroo | Riphagen | Prokopiou | Hanseeuw | Sperling | El Fakhri | Johnson | Jacobs | Koops, Elouise A. | Elouise A. Koops, Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Boston, MA, US |
POSTER SESSIONS: 3A - Friday, January 13, 9:15 - 10:00 am; 3B - Friday, January 13, 3:15 - 4:00 pm
Board # | Title | Authors | Presenter | Presenter/Affiliation |
---|---|---|---|---|
73 | Motion and partial volume corrections in dynamic [18F]-MK6240 PET imaging | Tiss | Gong | Lois | Becker | Thibault | Guehl | Xia | Normandin | Ouyang | Johnson | El Fakhri | Gong, Kuang | Kuang Gong, Gordon Center for Medical Imaging, Department of Imaging, Massachusetts General Hospital, Boston, MA, US |
74 | Encoding, consolidation and retrieval deficits are differentially shaped by tau and atrophy in the Alzheimer’s disease spectrum | Fernandez | Therriault | Lussier | Bezgin | Tissot | Servaes | Wang | Matothaarachchi | Stevenson | Rahmouni | Kang | Pallen | Kunach | Quispialaya | Margherita-Poltronetti | Pascoal | Rosa-Neto | Fernandez Arais, Jaime | Jaime Fernandez Arias, Montreal Neurological Institute, McGill University |
75 | Comorbid medical conditions, anxiety, and amyloid-β pathology in cognitively unimpaired older adults | Abiose | Young | Winer | Deters | Mormino | Abiose, Olamide | Olamide Abiose, Stanford University School of Medicine Department of Neurology & Neurological Sciences, Stanford, CA, US |
76 | Defining and characterizing neocortical tau resistance in preclinical Alzheimer’s disease | Buckley | Klinger | Boyle | Coughlan | Hanseeuw | Yang | Amariglio | Rentz | Townsend | Farrell | Jacobs | Shirzadi | Yau | Price | Chhatwal | Schultz | Hohman | Donohue | Properzi | Johnson | Sperling | Buckley, Rachel | Rachel Buckley, Massachusetts General Hospital, Department of Neurology, Boston, MA, US |
77 | Development and evaluation of image preprocessing pipelines for the Centiloid method | Luo | Minhas | Rubenstein | Situ | Royse | Ances | Christian | Cohen | Handen | Klunk | Tudorascu | Zamon | Laymon | Luo, Weiquan | Weiquan Luo, Department of Radiology, University of Pittsburgh, Pittsburgh, PA, US |
78 | Cognitively estimated disease time: Associations with amyloid and tau burden in the Harvard Aging Brain Study | Townsend | Properzi | Betthauser | Klinger | Boyle | Coughlan | Hanseeuw | Yang | Amariglio | Farrell | Jacobs | Shirzadi | Yau | Price | Chhatwal | Rentz | Johnson | Sperling | Schultz | Buckley | Townsend, Diana | Diana Townsend, Department of Neurology, Massachusetts General Hospital, Boston, MA, US |
79 | Synergistic interaction between sex, amyloid and phosphorylated tau predicts the longitudinal progression of tau tangles | Wang | Therriault | Servaes | Tissot | Fernandez Arias | Rahmouni | Macedo | Stevenson | Stevenson | Haeger | Hosseini | Nazneen | Rosa-Neto | Wang, Yi-Ting | Yi-Ting Wang, McGill Centre for Studies in Aging, Montreal, QC, CA |
80 | [18F]PI-2620 binding patterns in patients with suspected AD- and FTLD-tauopathies | Blazhenets | Soleimani-Meigooni | Thomas | Brendel | Vento | VandeVrede | Heuer | Ljubenkov | Rojas | Chen | Iaccarino | Mundada | Litvan | Grossman | Boeve | Pantelyat | Tartaglia | Irwin | Dickerson | Baker | Boxer | Rabinovici | La Joie | Blazhenets, Ganna | Ganna Blazhenets, Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, US |
81 | Regional analysis of change in synaptic density over time by cognitive status | DiFilippo | Mcvea | Mclachlan | Pasquesi | Davenport-Sis | Jonaitis | Ennis | Betthauser | Engle | Johnson | Bendlin | Christian | DiFilippo, Alexandra | Alexandra DiFilippo, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, US |
82 | Regional tau profiles in early tau pathology populations | Kotari | Morris | Svaldi | Southekal | Lu | Pontecorvo | Collins | Shcherbinin | Neuroimaging Initiative | Kotari, Vikas | Vikas Kotari, Eli Lilly and Company, Indianapolis, IN, US |
83 | [18F]MK-6240 tau-PET in an Aβ-enriched sample from the 1946 British birth cohort - Insight 46 | Coath | Markiewicz | Modat | Scott | Malone | Thomas | Dickson | Schöll | Ourselin | Richards | Fox | Cash | Schott | Coath, William | William Coath, Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, GB |
84 | Longitudinal trajectories of depressive symptoms and regional amyloid accumulation (PiB PET) in clinically normal older adults | Munro | Farrell | Hanseeuw | Buckley | Properzi | Vannini | Amariglio | Quiroz | Blacker | Rentz | Sperling | Johnson | Marshall | Gatchel | Munro, Catherine | Catherine Munro, Brigham and Women's Hospital, Boston, MA, US |
85 | Improving sub-threshold PiB fidelity using relative radioligand delivery | Properzi | Shirzadi | Buckley | Klinger | Hanseeuw | Amariglio | Rentz | Farrell | Price | Chhatwal | Marshall | Gatchel | Johnson | Sperling | Schultz | Properzi, Michael | Michael Properzi, Massachusetts General Hospital, Boston, MA, US |
86 | Improved prediction of preclinical cognitive decline using amyloid PET spatial extent | Farrell | Thibault | Becker | Price | Hanseeuw | Buckley | Papp | Jacobs | Rentz | Sperling | Johnson | Farrell, Michelle E. | Michelle E. Farrell, Massachusetts General Hospital, Harvard Medical School, Boston, MA, US |
87 | 18F-MK-6240 Tau PET as a Potential Biomarker for Chronic Traumatic Encephalopathy | Alosco | Mundada | La Joie | Asken | Nowinski | Smith | Culhane | Shankar | Amuiri | Pettway | Iaccarino | Windon | Tripodis | Mercier | Kowall | Stein | Grinberg | McKee | Stern | Miller | Mez | Killiany | Rabinovici | Asken, Breton | Breton Asken, PhD, University of Florida, Department of Clinical and Health Psychology |
88 | Psychosis and tau burden across the AD continuum | Johnson* | Ziaggi* | Huey, MD | Kreisl, MD | Talmasov, MD | Lao, PhD | Johnson, Aubrey S. | Aubrey Johnson, Columbia University Irving Medical Center |
89 | Classifying cognitive resilience to differing levels of Alzheimer’s disease pathology | Boyle | Townsend | Klinger | Coughlan | Hanseeuw | Yang | Amariglio | Farrell | Jacobs | Shirzadi | Yau | Price | Chhatwal | Schultz | Hohman | Donohue | Properzi | Rentz | Johnson | Sperling | Buckley | Boyle, Rory | Rory Boyle, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, US |
90 | Cerebrospinal fluid neurofilament light predicts increased amyloid, tau, and decreased grey matter density | Manchella | Logan | Dage | Hammers | Nemes | Kostadinova | Eloyan | Mundada | La Joie | Iaccarino | Fagan | Foroud | Zetterberg | Koeppe | Aisen | Carrillo | Rabinovici | Dickerson | Apostolova | Manchella, Mohit | Mohit Manchella, Indiana University School of Medicine, Indianapolis, IN, US |
91 | Unhealthy white matter connectivity in African American and non-Hispanic white older adults | Royse | Snitz | Hengenius | Huppert | Roush | Cisneros | Potopenko | Becker | Cohen | Shaaban | Royse, Sarah | Sarah Royse, Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, US |
92 | Locus coeruleus integrity as neural substrate providing resilience against cognitive decline in the face of Alzheimer’s disease pathology | Jacobs | Papp | Buckley | Riphagen | Hanseeuw | Boyle | Donovan | Rentz | Sperling | Johnson | Jacobs, Heidi IL | Heidi IL Jacobs, Massachusetts General Hospital, Gordon Center for Medical Imaging, Boston, MA, US |
93 | Lower locus coeruleus integrity predicts diminished practice effects in cognitively normal older individuals | Smegal | Schneider | Jutten | Rentz | Johnson | Sperling | Papp | Jacobs | Smegal, Lindsay | Lindsay Smegal, Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital/ Harvard Medical School, Boston, MA, US |
94 | PET-based Braak staging predicts neuropsychiatric burden in the Alzheimer’s disease continuum | Macedo | Tissot | Therriault | Servaes | Rahmouni | Fernandez-Arias | Z. Lussier | Stevenson | Wang | Quispialaya Socualaya | Nazneen | Ali Hosseini | Kunach | Haeger | Stevenson | Vitali | A. Pascoal | Rosa-Neto | C. Macedo, Arthur | Arthur C. Macedo, McGill University, Montreal, QC, CA |
95 | A computational model to study the combined effect of neuronal connectivity loss and tauopathy progression | Rahimabadi | Soucy | Benali | Rahimabadi, Arsalan | Arsalan Rahimabadi, PERFORM Centre, Concordia University, Montreal, QC, CA |
96 | Simulated dose reduction in longitudinal [18F]MK-6240 PET | McLachlan | McVea | DiFilippo | Schöll | Betthauser | Johnson | Christian | McLachlan, Max | Max McLachlan, Department of Medical Physics, University of Wisconsin – Madison, School of Medicine and Public Health, Madison, WI, US |
97 | Regional amyloid change improves prediction of future tau progression over global metrics | Thibault | Farrell | Properzi | Mayblyum | Hanseewu | Healy | Price | Becker | Sperling | Johnson | Thibault, Emma | Emma Thibault, Massachusetts General Hospital, Boston, MA, US |
99 | Rates of tau PET accumulation along the amyloid timeline in Alzheimer’s disease | Cody | Langhough | Christian | Betthauser | Johnson | Cody, Karly | Karly Cody, Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin-Madison, Madison, WI, US |
100 | Body mass index, pathological tau, and cognition in preclinical AD: Could women with high BMI be protected? | Wang | Sundermann | Buckley | Reas | McEvoy | Banks | Wang, Xin | Xin Wang, Department of Neurosciences, University of California, San Diego., La Jolla, CA, US |
101 | Amyloid drives later tau accumulation for fast progressors in early Braak stages | Servaes | Therriault | Tissot | Lussier | Bezgin | Wang | Stevenson | Rahmouni | Stevenson | Pallen | Kunach | Fernandez Arias | Cassa Macedo | Hosseini | Pascoal | Gauthier | Rosa-Neto | Servaes, Stijn | Stijn Servaes, Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, Montreal, QC, CA |
102 | Brain-wide and AD-risk genetic expression: A descriptive study | Hobbs | McCullough | Millar | Gordon | Hobbs, Diana | Diana Hobbs, Washington University in St. Louis, St. Louis, MO, US |
103 | Behavioral brain networks underlying the effect of Alzheimer’s pathology on cognition | Ziontz | Harrison | Jagust | Ziontz, Jacob | Jacob Ziontz, Helen Wills Neuroscience Institute, University of California Berkeley,, Berkeley, CA, US |
104 | Exploration of 18F-Florzolotau tau PET distribution patterns using machine learning approach in AD | Huang | Lee | Lin | Huang | Hsu | Chang | Huang | Hsiao | Huang, Shao-Yi | Shao-Yi Huang, Medical Imaging & Radiological Sciences and Healthy Aging Research Center, Chang Gung University, Taoyuan, TW |
105 | The interplay of vascular disease, peripheral interleukin-6, beta-amyloid, and memory in older adults | Rizvi | Adams | Sathishkumar | Kim | Larson | McMillan | Brickman | Mapstone | Thomas | Greenia | Corrada | Kawas | Yassa | Rizvi, Batool | Batool Rizvi, University of California, Irvine, Irvine, CA, US |
106 | Gut microbiome composition is associated with cortical amyloid burden in a preclinical human cohort | Heston | González | Betthauser | Johnson | Asthana | Knight | Kaddurah-Daouk | Rey | Bendlin | Heston, Margo | Margo Heston, Wisconsin Alzheimer's Disease Research Center, Madison, WI, US |
107 | Study on MR-free template-based spatial normalization for Tau PET Image Quantitation using 18F-Florzolotau | Lee | Huang | Lin | Huang | Huang | Wu | Chang | Hsiao | Lee, Zih-Ning | Zih-Ning Lee, Medical Imaging & Radiological Sciences and Healthy Aging Research Center, Chang Gung University, Taoyuan, TW |
108 | β-Amyloid in World Trade Center responders: Result indicate age-related toxic encephalopathy mediated by an immunogenic amyloid response | Clouston | Vaska | Huang | Kritikos | Zhou | Vaska, Paul | Paul Vaska, Stony Brook University, Stony Brook, NY, US |
109 | [18F]MK-6240 PET/MRI Test-Retest performance in cognitively normal elderly subjects | Lois | Fanglu Fu | Salvatore | Huell | Izquierdo Garcia | Garimella | Dickerson | Johnson | Catana | Price | Lois, Cristina | Cristina Lois, Gordon Center for Medical Imaging, Massachusetts General Hospital, Boston, MA, US |
HAI Past Poster Sessions



















